Cabel - I’m inclined to agree that there must be something in the Cognition results, and I’m guessing in DM’s webcast thereafter, that will drive the SP to a higher level.  Otherwise why pump money into what would continue to be a company with promise but nothing that, at this stage, excites the market beyond current levels for the sake of gaining a financial leg up of a dollar or two, or three. We also have the possibility of some news on the FDA front before Xmas.

So, unless I’m missing something it’s hard for me to view this as anything but positive, to say the least.